Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: Streptokinase with longer functional half- life

Applied and Environmental Microbiology

Volumn 64, Issue 3, 1998, Pages 824-829

  Wu, Xu Chu ^a   Ye, Ruiqiong ^a   Duan, Yanjun ^a   Wong, Sui Lam ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMIN; STREPTOKINASE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BACILLUS SUBTILIS; BACTERIUM MUTANT; GENETIC ENGINEERING; HALF LIFE TIME; NONHUMAN; PLASMINOGEN ACTIVATION; SITE DIRECTED MUTAGENESIS;

EID: 0031951905     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.64.3.824-829.1998     Document Type: Article

References (51)

1. Bajaj, A. P., and F. J. Castellino. 1977. Activation of human plasminogen by equimolar levels of streptokinase. J. Biol. Chem. 252:492-498.
2. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248-254.
3. Breton, J., N. Pezzi, A. Molinari, L. Bonomini, J. Lansen, G. Gonzalez De Buitrago, and I. Prieto. 1995. Prolonged half-life in the circulation of a chemical conjugate between a pro-urokinase derivative and human serum albumin. Eur. J. Biochem. 231:563-569.
4. Brockway, W. J., and F. J. Castellino. 1974. A characterization of native streptokinase and altered streptokinase isolated from a human plasminogen activator complex. Biochemistry 13:2063-2070.
5. Brucato, F. H., and S. V. Pizzo. 1990. Catabolism of streptokinase and polyethylene glycol-streptokinase: evidence for transport of intact forms through the biliary system in the mouse. Blood 76:73-79.
6. Cannon, C. P., and S. Z. Goldhaber. 1995. The importance of rapidly treating patients with acute myocardial infarction. Chest 107:598-600.
7. Castellino, F. J., J. M. Sodetz, W. J. Brockway, and G. E. Siefring, Jr. 1976. Streptokinase. Methods Enzymol. 45:244-257.
8. Davidson, D. J., D. L. Higgins, and F. J. Castellino. 1990. Plasminogen activator activities of equimolar complexes of streptokinase with variant recombinant plasminogens. Biochemistry 29:3585-3590.
9. Deutsch, D. G., and E. T. Mertz. 1970. Plasminogen: purification from human plasma by affinity chromatography. Science 170:1095-1096.
10. Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardico. 1990. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 336:65-71.
11. GUSTO Angiographic Investigators. 1993. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N. Engl. J. Med. 329: 1615-1622.
12. 11a. GUSTO Angiographic Investigators. 1993. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N. Engl. J. Med. 329:673-682.
13. Halling, S. M., F. J. Sanchez-Anzaldo, R. Fukuda, R. H. Doi, and C. F. Meares. 1977. Zinc is associated with the beta subunit of DNA dependent RNA polymerase of Bacillus subtilis. Biochemistry 16:2880-2884.
14. Hemsley, A., N. Arnheim, M. D. Toney, G. Cortopassi, and D. J. Galas. 1989. A simple method for site-directed mutagenesis using the polymerase chain reaction. Nucleic Acids Res. 17:6545-6551.
15. Hennekens, C. H., C. J. O'Donnell, P. M. Ridker, and V. J. Marder. 1995. Current issues concerning thrombolytic therapy for acute myocardial infarction. J. Am. Coll. Cardiol. 25:18S-22S.
16. Houng, A., S. Quen, L.-F. Jean, and G. L. Reed. 1995. Construction of a recombinant streptokinase that resists cleavage and inactivation by plasmin. Thromb. Haemostasis 73:1130. (Abstract.)
17. Huber, K. and G. Maurer. 1996. Thrombolytic therapy in acute myocardial infarction. Semin. Thromb. Hemostasis 22:15-26.
18. ISIS-3 Collaborative Group. 1992. ISIS-3: A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 339:753-770.
19. Jackson, K. W., H. Malke, D. Gerlach, J. J. Ferretti, and J. Tang. 1986. Active streptokinase from the cloned gene in Streptococcus sanguis is without the carboxyl-terminal 32 residues. Biochemistry 25:108-114.
20. Keyt, B. A., N. F. Paoni, C. J. Refino, L. Berleau, H. Nguyen, A. Chow, J. Lai, L. Peña, C. Pater, and J. Ogez. 1994. A faster-acting and more potent form of tissue plasminogen activator. Proc. Natl. Acad. Sci. USA 91:3670-3674.
21. Kim, I. C., J. S. Kim, S. H. Lee, and S. M. Byun. 1996. C-terminal peptide of streptokinase, Met369-Pro373, is important in plasminogen activation. Biochem. Mol. Biol. Int. 40:939-945.
22. Lee, B. R., S. K. Park, J. H. Kim, and S. M. Byun. 1989. Site-specific alteration of Gly-24 in streptokinase: its effect on plasminogen activation. Biochem. Biophys. Res. Commun. 165:1085-1090.
23. Lee, S. H., S. T. Jeong, I. C. Kim, and S. M. Byun. 1997. Identification of the functional importance of valine-19 residue in streptokinase by N-terminal deletion and site-directed mutagenesis. Biochem. Mol. Biol. Int. 41:199-207.
24. Lin, L. F., S. Oeun, A. Houng, and G. L. Reed. 1996. Mutation of lysines in a plasminogen binding region of streptokinase identifies residues important for generating a functional activator complex. Biochemistry 35:16879-16885.
25. Madison, E. 1994. Probing structure-function relationships of tissue-plasminogen activator by site-specific mutagenesis. Fibrinolysis 8:221-236.
26. Malke, H., and J. J. Ferretti. 1984. Streptokinase: cloning, expression, and excretion by Escherichia coli. Proc. Natl. Acad. Sci. USA 81:3557-3561.
27. Matsudaira, P. 1987. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 262: 10035-10038.
28. Maynard, C., R. Althouse, M. Olsufka, J. L. Ritchie, K. B. Davis, and J. W. Kennedy. 1989. Early versus late hospital arrival for acute myocardial infarction in the Western Washington Thrombolytic Therapy Trials. Am. J. Cardiol. 63:1296-1300.
29. McClinock, D. K., M. E. Englert, C. Dziobkowski, E. H. Snedeker, and P. H. Bell. 1974. Two distinct pathways of the streptokinase-mediated activation of highly purified human plasminogen. Biochemistry 13:5334-5344.
30. Nihalani, D., and G. Sahni. 1995. Streptokinase contains two independent plasminogen-binding sites. Biochem. Biophys. Res. Commun. 217:1245-1254.
31. Rawles, J. 1994. Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT). J. Am. Coll. Cardiol. 23:1-5.
32. Reed, G. L., L.-F. Lin, B. Parhami-Seren, and P. Kussie. 1995. Identification of a plasminogen binding region in streptokinase that is necessary for the creation of a functional streptokinase-plasminogen activator complex. Biochemistry 34:10266-10271.
33. Rodríguez, P., P. Fuentes, M. Barro, J. G. Alvarez, E. Muñoz, D. Collen, and H. R. Lijnen. 1995. Structural domains of streptokinase involved in the interaction with plasminogen. Eur. J. Biochem. 229:83-90.
34. Rozenman, Y., M. Gotsman, T. Weiss, C. Lotan, M. Mosseri, D. Sapoznikov, S. Welber, H. Nassar, Y. Hasin, and D. Gilon. 1994. Very early thrombolysis in acute myocardial infarction - a light at the end of the tunnel. Isr. J. Med. Sci. 30:99-107.
35. Rozenman, Y., M. S. Gotsman, A. T. Weiss, C. Lotan, M. Mosseri, D. Sapoznikov, S. Welber, Y. Hasin, and D. Gilon. 1995. Early intravenous thrombolysis in acute myocardial infarction: the Jerusalem experience. Int. J. Cardiol. 49(Suppl.):S21-S28.
36. Saiki, R. K., D. H. Gelfand, S. Stoffel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491.
37. Saksela, O. 1981. Radial caseinolysis in agarose: a simple method for detection of plasminogen activators in the presence of inhibitory substances and serum. Anal. Biochem. 111:276-282.
38. Schlott, B., K. H. Guhrs, M. Hartmann, A. Rocker, and D. Collen. 1997. Staphylokinase requires NH2-terminal proteolysis for plasminogen activation. J. Biol. Chem. 272:6067-6072.
39. Shi, G.-Y., B.-I. Chang, S.-M. Chen, D.-H. Wu, and H.-L. Wu. 1994. Function of streptokinase fragments in plasminogen activation. Biochem. J. 304:235-241.
40. Siefring, G. E., Jr. and F. J. Castellino. 1976. Interaction of streptokinase with plasminogen: isolation and characterization of a streptokinase degradation product. J. Biol. Chem. 251:3913-3920.
41. Smith, R. A., R. J. Dupe, P. D. English, and J. Green. 1981. Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature 290:505-508.
42. Steinmetz, M., D. LeCoq, S. Aymerich, G. Gonzy-Treboul, and P. Gay. 1985. The DNA sequence of the secreted Bacillus subtilis enzyme levansucrase and its genetic control sites. Mol. Gen. Genet. 200:220-228.
43. 2-terminal lysine forms of human plasminogen isolated by affinity chromatography and isoelectric focusing methods. J. Biol. Chem. 248:2984-2991.
44. 43 operon of Bacillus subtilis. Mol. Gen. Genet. 207:114-119.
45. Weaver, W. D., M. Cerqueira, A. P. Hallstrom, P. E. Litwin, J. S. Martin, P. J. Kudenchuk, and M. Eisenberg. 1993. The Myocardial Infarction Triage and Intervention Project Group: prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 270:1211-1216.
46. Weinstein, M. J. and R. F. Doolittle. 1972. Differential specificities of thrombin, plasmin and trypsin with regard to synthetic and natural substrates and inhibitors. Biochim. Biophys. Acta 258:577-582.
47. Wohl, R. C., L. Summaria, and K. C. Robbins. 1980. Kinetics of activation of human plasminogen by different activator species at pH 7.4 and 37 degrees C. J. Biol. Chem. 255:2005-2013.
48. Wong, S.-L. 1989. Development of an inducible and enhancible expression and secretion system in Bacillus subtilis. Gene 83:215-223.
49. Wong, S.-L., R. Ye, and S. Nathoo. 1994. Engineering and production of streptokinase in a Bacillus subtilis expression-secretion system. Appl. Environ. Microbiol. 60:517-523.
50. Wu, X.-C., W. Lee, L. Tran, and S.-L. Wong. 1991. Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases. J. Bacteriol. 173:4952-4958.
51. Young, K.-C., G.-Y. Shi, Y.-F. Chang, B.-I. Chang, L.-C. Chang, M.-D. Lai, W.-J. Chuang, and H.-L. Wu. 1995. Interaction of streptokinase and plasminogen - studied with truncated streptokinase peptides. J. Biol. Chem. 270: 29601-29606.